Open AccessCancer Stage, Treatment, and Survival Among Transgender Patients in the United States
Author(s) -
Sarah Jackson,
Xuesong Han,
Ziling Mao,
Letícia Nogueira,
Gita Suneja,
Ahmedin Jemal,
Meredith S. Shiels
Publication year - 2021
Publication title -
journal of the national cancer institute
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.797
H-Index - 356
eISSN - 1460-2105
pISSN - 0027-8874
DOI - 10.1093/jnci/djab028
Subject(s) - medicine , hazard ratio , cancer , transgender , confidence interval , odds ratio , population , stage (stratigraphy) , cancer registry , prostate cancer , proportional hazards model , lung cancer , psychology , paleontology , environmental health , psychoanalysis , biology
Transgender persons face many barriers to health care that may delay cancer diagnosis and treatment, possibly resulting in decreased survival. Yet, data on cancer in this population are limited. We examined cancer stage at diagnosis, treatment, and survival among transgender patients compared with cisgender patients in the National Cancer Database (NCDB).